Clinical Trial Update: Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the efficacy and safety of bevacizumab given in the neoadjuvant setting for inflammatory breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Association Tunisienne de lutte Contre le Cancer | Conditions: Inflammatory Breast Cancer | Phase 1 | Status: UNKNOWN